RISC
Retrospective International Study of Invasive/Advanced Cancer of the Urothelium
This project is establishing a large retrospective database detailing the care of patients with advanced bladder cancer (and other cancers of the urothelial tract) for the purposes of:
- Generating insights regarding patterns of care
- Exploring prognostic and predictive variables
- Informing future clinical trial design
- Performing comparative effectiveness analyses
- Assessing the impact of comorbidities on patient outcomes
Each of these analyses will be used to enhance the care of future patients with cancers of the bladder (and other cancers of the urothelial tract). RISC is an international, multi-center, collaborative effort with Mount Sinai functioning as the data coordinating center.
Steering Committee
Matthew D. Galsky, MD, Icahn School of Medicine/Tisch Cancer Institute
Jonathan Rosenberg, MD, Harvard Medical School/Dana-Farber Cancer Institute
Joaquim Bellmunt, MD, University Hospital Del Mar-IMIM
Toni Choueiri, MD, Harvard Medical School/Dana-Farber Cancer Institute
Thomas Powles, MD, Barts and London School of Medicine
Noah Hahn, MD, Indiana University/Simon Cancer Center
Robert Dreicer, MD, Cleveland Clinic/Taussig Cancer Center
Guru Sonpavde, MD, Texas Oncology/US Oncology
Cora Sternberg, MD, San Camillo Forlanini Hospital
Yu-Ning Wong, MD, Fox Chase Cancer Center
William K. Oh, MD, Icahn School of Medicine/Tisch Cancer Institute
Icahn School of Medicine Staff
Steven Grossman, Clinical Research Supervisor, Icahn School of Medicine/Tisch Cancer Institute
Tiffany Yee, Clinical Research Coordinator, Icahn School of Medicine/Tisch Cancer Institute
Ryan Hendricks, Clinical Research Coordinator, Icahn School of Medicine/Tisch Cancer Institute